Vanda Pharmaceuticals

This study tested whether an experimental drug called ANB019 (imsidolimab) could reduce painful blisters and scaling on the palms and soles in adults with palmoplantar pustulosis. 59 participants received either the drug or a placebo injection to compare safety and effectiveness …

This study tested whether a new drug called imsidolimab could reduce painful lumps and sores in people with hidradenitis suppurativa (HS), a chronic inflammatory skin disease. 149 adult participants with moderate to severe HS were randomly assigned to receive either the drug or a…

This study tested whether a new injectable drug called imsidolimab could safely reduce acne breakouts. About 123 teenagers and adults with moderate to severe facial acne received either the drug or a placebo (dummy shot) over 20 weeks. Researchers counted pimples and assessed ski…

This study compared a new tablet called VHX-896 to an existing drug, iloperidone, in people with schizophrenia or bipolar I disorder. The main goal was to see if the new tablet gets into the bloodstream the same way as the old one. Researchers also checked how safe and tolerable …

This study tested whether a medication called imsidolimab (ANB019) could help adults with severe generalized pustular psoriasis, a rare and painful skin condition. Eight participants received the drug to see if it reduced their skin lesions, pustules, and other symptoms. Research…

This study tested whether the drug imsidolimab could help adults with generalized pustular psoriasis, a rare and severe skin condition that causes painful pus-filled bumps. Researchers compared the drug against a placebo in 45 participants to see if it could clear or nearly clear…

This study tested if a drug called tradipitant could reduce the common side effects of nausea and vomiting caused by GLP-1 agonist medications, which are used for weight loss. It involved 124 healthy, overweight volunteers who took either tradipitant or a placebo (a dummy pill) a…

This study tested whether a new eye drop called VSJ-110 is safe and works better than a placebo (a dummy treatment with no medicine) at relieving the symptoms of allergic conjunctivitis (eye allergies). Researchers gave the drops to 47 adult volunteers and then triggered their al…